fda glp-1 compounding crackdown september 2025 to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads FDA Crackdown on Compounded GLP-1

As of June 2025, the branded version of liraglutide, Saxenda, generated $165 million in annual sales alone, and the market for GLP-1s could be set to hit over $126 billion in sales by 2029

Contraception & Pregnancy Because delayed gastric emptying may affect absorption of oral contraceptives, alternative or backup contraception may be recommended

The intestinal lumen receives a large quantity of hepatic GSH from biliary secretion

These biochemical adaptations result in a metabolic reprogramming that promotes lactate production and accumulation, thereby reinforcing the hypoxic cellular response

Ozempic is only approved by the Food and Drug Administration (FDA) for patients with type 2 diabetes, though off-label use for weight loss has become increasingly common

The exposed, charged surfaces of these crystals are thought to promote interactions with phospholipid membranes and serum factors, thereby contributing to the inflammatory response mediated by these crystals